Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00833144 · ClinicalTrials.gov registry record

Bedside Ultrasound Identifies Congestive Heart Failure

A clinical trial, sponsored by Emory University.

Completed
Registry status
375
Enrollment target

NCT00833144: Completed study, sponsored by Emory University.

NCT00833144 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 375 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00833144 has completed, sponsored by Emory University.

COMPLETED
Registry status
375 participants
Enrollment target

Study Summary

Patients often arrive to the Emergency Department with the chief complaint of shortness of breath. The cause of the shortness of breath may be due to many things, such as pneumonia, emphysema, a heart attack, heart failure, and others. It is often very difficult for the physician to determine the cause of the shortness of breath in the first two hours in the Emergency Department. This ambiguity makes treating the patient very difficult. Although a patient could benefit from treatment upon arrival, the emergent treatment of the condition must wait until a final diagnosis is made. Recently, emergency physicians have been using portable ultrasound at the patient's bedside to diagnose numerous conditions, including trauma, blood clots, kidney stones, etc. Recent research suggests that heart failure, one of the causes of shortness of breath, may be diagnosed within 5 minutes or less using ultrasound. Most of these studies come from the intensive care and cardiology. However, no research has yet been performed to determine if emergency physicians can effectively use ultrasound to quickly diagnose and treat heart failure within the first few minutes of a patient's arrival to the emergency department. The hypothesis of this study is to evaluate the ability of residents in emergency medicine to use ultrasound to diagnose patients in heart failure who presented with the chief complaint of shortness of breath. The final diagnosis of the patient upon discharge from the hospital will be compared to the preliminary diagnosis based on the portable ultrasound findings.

Trial Details

FieldValue
Enrollment Target 375 participants
Start Date 2009-02
Est. Completion 2011-02
Emory University

1,208 total trials

What the finished NCT00833144 record still lists

NCT00833144 is an observational study that tracks outcomes without assigning an intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00833144 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00833144 about?

NCT00833144 is a clinical study titled "Bedside Ultrasound Identifies Congestive Heart Failure". Patients often arrive to the Emergency Department with the chief complaint of shortness of breath. The cause of the shortness of breath may be due to many things, such as pneumonia, emphysema, a heart attack, heart failure, and others. It is often very difficult for the physician to determine the ca...

What is the current status of trial NCT00833144?

This trial is currently completed. The enrollment target is 375 participants. The study started on 2009-02. Estimated completion is 2011-02.

Who is sponsoring clinical trial NCT00833144?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03686124 · 375 participants · Phase 1

    ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • NCT04059172 · 375 participants · Early Phase 1

    Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management

  • NCT04134923 · 375 participants

    Imaging Biomarkers in Preclinical and Symptomatic AD

  • NCT04569747 · 375 participants · Phase 2

    A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00833144, the US trial registry maintained by the National Library of Medicine. NCT00833144 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.